Sudeep Pharma IPO Day 2: Subscription Hits 2.62x – GMP, Review & Should You Apply?
The Sudeep Pharma IPO entered its second day of subscription on November 24, 2025, and the buzz is real. The offer is already oversubscribed, underscoring strong early demand. Backed by a grey-market premium (GMP) hovering near ₹120, many investors are betting on solid listing gains. The company is looking to raise ₹895 crore, with shares priced between ₹563 and ₹593.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
